Stay updated with breaking news from Stefan siebert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
France, India to provide medical oxygen support in the form of enhancement of COVID-19 0 1 1 minute read Paris: The French President said on Sunday (25 April) that France plans to help India cope with a record surge in COVID-19 cases with medical oxygen capacity in the coming days. It comes hours after the German Chancellor Angela Merkel, British Prime Minister Boris johnson, And the European Union announced plans to assist India against an epidemic that led to the storage of hospital beds and medical-grade oxygen in the country. Expressing solidarity with the people of India to counter COVID-19, the German Chancellor stated that they are preparing “a mission to support” India. “To the people of India, I want to express my sympathy for that terrible.” COVID-19 Have brought their communities back again. The fight against pandemics is our common battle. Germany stands in solidarity with India and is preparing a mission of immediate support, ”Merkel said i ....
The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate t ....
Search jobs UofG Announces Research Collaboration with Lilly to Discover Potential New Drug Targets The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate the next generation of drug targets for immunological diseases. The £4.6million research collaboration, due to last four years, will work across four diseases – psoriatic arthritis, rheumatoid arthritis, fibrosis and vasculitis – and will be led by the University of Glasgow’s Institute of Infection, Immunity and Inflammation. The collaboration will allow scientists from UofG and Lilly to work together in order to drive the research forward – a move researchers hope will help enable the identification of first-in-class therapeutics for people suffering with these devastating and costly conditions. For instance, rheumatoid arthritis alone affects 0.3-1% of people across the globe and ....